Literature DB >> 24042118

Trimeric autotransporter DsrA is a major mediator of fibrinogen binding in Haemophilus ducreyi.

William G Fusco1, Christopher Elkins, Isabelle Leduc.   

Abstract

Haemophilus ducreyi is the etiologic agent of the sexually transmitted genital ulcer disease chancroid. In both natural and experimental chancroid, H. ducreyi colocalizes with fibrin at the base of the ulcer. Fibrin is obtained by cleavage of the serum glycoprotein fibrinogen (Fg) by thrombin to initiate formation of the blood clot. Fg binding proteins are critical virulence factors in medically important Gram-positive bacteria. H. ducreyi has previously been shown to bind Fg in an agglutination assay, and the H. ducreyi Fg binding protein FgbA was identified in ligand blotting with denatured proteins. To better characterize the interaction of H. ducreyi with Fg, we examined Fg binding to intact, viable H. ducreyi bacteria and identified a novel Fg binding protein. H. ducreyi bound unlabeled Fg in a dose-dependent manner, as measured by two different methods. In ligand blotting with total denatured cellular proteins, digoxigenin (DIG)-Fg bound only two H. ducreyi proteins, the trimeric autotransporter DsrA and the lectin DltA; however, only the isogenic dsrA mutant had significantly less cell-associated Fg than parental strains in Fg binding assays with intact bacteria. Furthermore, expression of DsrA, but not DltA or an empty vector, rendered the non-Fg-binding H. influenzae strain Rd capable of binding Fg. A 13-amino-acid sequence in the C-terminal section of the passenger domain of DsrA appears to be involved in Fg binding by H. ducreyi. Taken together, these data suggest that the trimeric autotransporter DsrA is a major determinant of Fg binding at the surface of H. ducreyi.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24042118      PMCID: PMC3837977          DOI: 10.1128/IAI.00743-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers.

Authors:  M E Bauer; M P Goheen; C A Townsend; S M Spinola
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 2.  Haemophilus ducreyi: clinical features, epidemiology, and prospects for disease control.

Authors:  Cliffton T H Bong; Margaret E Bauer; Stanley M Spinola
Journal:  Microbes Infect       Date:  2002-09       Impact factor: 2.700

3.  Molecular characterization of the EhaG and UpaG trimeric autotransporter proteins from pathogenic Escherichia coli.

Authors:  Makrina Totsika; Timothy J Wells; Christophe Beloin; Jaione Valle; Luke P Allsopp; Nathan P King; Jean-Marc Ghigo; Mark A Schembri
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

4.  Cloning, overexpression, purification, and immunobiology of an 85-kilodalton outer membrane protein from Haemophilus ducreyi.

Authors:  K L Thomas; I Leduc; B Olsen; C E Thomas; D W Cameron; C Elkins
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  The Haemophilus ducreyi serum resistance antigen DsrA confers attachment to human keratinocytes.

Authors:  Leah E Cole; Thomas H Kawula; Kristen L Toffer; Christopher Elkins
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  Serum resistance in Haemophilus ducreyi requires outer membrane protein DsrA.

Authors:  C Elkins; K J Morrow; B Olsen
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  DsrA-deficient mutant of Haemophilus ducreyi is impaired in its ability to infect human volunteers.

Authors:  C T Bong; R E Throm; K R Fortney; B P Katz; A F Hood; C Elkins; S M Spinola
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 8.  Chancroid: from clinical practice to basic science.

Authors:  D A Lewis
Journal:  AIDS Patient Care STDS       Date:  2000-01       Impact factor: 5.078

Review 9.  Chancroid: clinical manifestations, diagnosis, and management.

Authors:  D A Lewis
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

10.  A novel lectin, DltA, is required for expression of a full serum resistance phenotype in Haemophilus ducreyi.

Authors:  Isabelle Leduc; Patricia Richards; Crystal Davis; Birgit Schilling; Christopher Elkins
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

View more
  5 in total

1.  The Haemophilus ducreyi trimeric autotransporter adhesin DsrA protects against an experimental infection in the swine model of chancroid.

Authors:  William G Fusco; Neelima R Choudhary; Patty A Routh; Melissa S Ventevogel; Valerie A Smith; Gary G Koch; Glen W Almond; Paul E Orndorff; Gregory D Sempowski; Isabelle Leduc
Journal:  Vaccine       Date:  2014-05-18       Impact factor: 3.641

2.  Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA.

Authors:  William G Fusco; Neelima R Choudhary; Shelley M Stewart; S Munir Alam; Gregory D Sempowski; Christopher Elkins; Isabelle Leduc
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-04

3.  Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface.

Authors:  Melissa Samo; Neelima R Choudhary; Kristina J Riebe; Ivo Shterev; Herman F Staats; Gregory D Sempowski; Isabelle Leduc
Journal:  Vaccine       Date:  2016-01-24       Impact factor: 3.641

4.  Molecular phylogenetic analysis of non-sexually transmitted strains of Haemophilus ducreyi.

Authors:  Jordan R Gaston; Sally A Roberts; Tricia L Humphreys
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

5.  A novel intrinsically disordered outer membrane lipoprotein of Aggregatibacter actinomycetemcomitans binds various cytokines and plays a role in biofilm response to interleukin-1β and interleukin-8.

Authors:  Tuuli Ahlstrand; Heidi Tuominen; Arzu Beklen; Annamari Torittu; Jan Oscarsson; Raija Sormunen; Marja T Pöllänen; Perttu Permi; Riikka Ihalin
Journal:  Virulence       Date:  2016-07-26       Impact factor: 5.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.